Antifungal activities and cytotoxicity studies of six new azasordarins

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 11, 2001, Pages 3132-3139

  Herreros, E ^a   Almela, M J ^a   Lozano, S ^a   Gomez de las Heras, F ^a   Gargallo Viola, D ^a  

^a GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; AZASORDARIN DERIVATIVE; COTRIMOXAZOLE; FLUCONAZOLE; GW 471552; GW 471558; GW 479821; GW 515716; GW 570009; GW 587270; PENTAMIDINE ISETHIONATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; FUNGUS CULTURE; LIVER CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ANTIBIOTICS, ANTINEOPLASTIC; ARTHRODERMATACEAE; CELL SURVIVAL; CULTURE MEDIA; FUNGI; HUMANS; INDENES; MALE; MICROBIAL SENSITIVITY TESTS; PNEUMOCYSTIS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED; YEASTS;

EID: 0034775138     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.11.3132-3139.2001     Document Type: Article

References (21)

1. Pharmacokinetics-pharmacodynamics of a sordarin derivative (GM 237354) in a murine model of lethal candidiasis
2. In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats
3. The application of in vitro models of drug metabolism and toxicity in drug discovery and drug development
4. Evaluation of drug efficacy by using animal models or in vitro systems
5. Translation elongation factor 2 is part of the target for a new family of antifungals
6. Efficacies of sordarin derivatives GM 193663, GM 211676, and GM 237354 in a murine model of systemic coccidioidomycosis
7. Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans
8. Sordarin inhibits fungal protein synthesis by blocking translocation differently to fusidic acid
9. Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts
10. Prevention of infection due to Pneumocystis carinii
11. Sordarins as antifungal compounds
12. Biochemical functionality and recovery of hepatocytes after deep freezing storage
13. Activities of sordarins in murine histoplasmosis
14. Sordarins: In vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi
15. Microplate assays for in vitro evaluation of anti-Pneumocystis drugs
16. Antifungal efficacy of GM237354 derivative, in experimental oral candidiasis in immunosuppressed rats
17. Activities of sordarins in experimental models of candidiasis, aspergillosis, and pneumocystosis
18. Nosocomial fungal infections
19. General aspects of drug-induced liver diseases